Tinair
Indicated for smoking cessation, this treatment supports patients in quitting smoking. It works by selectively binding to nicotinic receptors in the brain, helping to reduce anxiety and withdrawal symptoms associated with smoking cessation, while simultaneously decreasing the reward and satisfaction derived from tobacco use.
Therapeutic Area
Smoking Cessation + Pulmonology
Active Ingredient
Cytisinicline
Line
Respiratory
Dosage Forms:
1.5 mg x 100 tablets
